Invitae Shares outstanding
What is the Shares outstanding of Invitae?
The Shares outstanding of Invitae Corporation is 74.617M
What is the definition of Shares outstanding?
Shares outstanding are all the shares of a corporation or of a financial asset that have been authorized, issued and purchased by investors and are held by them.
= issued shares - treasury shares
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Shares outstanding of companies in the Miscellaneous sector on LSE compared to Invitae
What does Invitae do?
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Companies with shares outstanding similar to Invitae
- Eaton Vance Tax Advantaged Dividend Income Fund has Shares outstanding of 74.543M
- M.D.C has Shares outstanding of 74.546M
- Orasure Technologies has Shares outstanding of 74.568M
- Stereotaxis has Shares outstanding of 74.581M
- RTI Surgical has Shares outstanding of 74.601M
- Brookfield Business Partners LP has Shares outstanding of 74.612M
- Invitae has Shares outstanding of 74.617M
- AGCO has Shares outstanding of 74.642M
- Temenos AG has Shares outstanding of 74.675M
- MBH PLC has Shares outstanding of 74.683M
- Galantas Gold has Shares outstanding of 74.684M
- Fjordland Exploration has Shares outstanding of 74.684M
- Align Technology has Shares outstanding of 74.697M